TCS, HDFCBANK, SBI Liquid Fund (G)
Natco Pharma Ltd.
Natco Pharma
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 17 06 2021 | Interim Dividend & Audited Results |
| 12 08 2021 | Quarterly Results & Interim Dividend |
| 11 11 2021 | Quarterly Results & Interim Dividend |
| 14 02 2022 | Third Interim Dividend & Quarterly Results |
| 30 05 2022 | Audited Results |
| 09 08 2022 | Interim Dividend & Quarterly Results |
| 10 11 2022 | Quarterly Results & Second Interim Dividend |
| 09 02 2023 | Quarterly Results & Interim Dividend |
| 08 03 2023 | Buy Back of Shares |
| 29 05 2023 | Audited Results |
| 09 08 2023 | Quarterly Results & Interim Dividend |
| 14 11 2023 | Quarterly Results & Interim Dividend |
| 14 02 2024 | Interim Dividend & Quarterly Results |
| 12 11 2024 | Quarterly Results & Interim Dividend |
| 12 02 2025 | Quarterly Results & Interim Dividend |
News
No News data available
